French food and beverage giant Danone announced plans to acquire U.K.-based protein shake maker Huel for an undisclosed sum, as both companies confirmed on Monday [1]. The Financial Times, citing a person close to the company, reported the deal is valued at approximately 1 billion euros ($1.15 billion), though Danone declined to comment on the transaction's value [1]. The acquisition is subject to regulatory approvals [1].
Danone CEO Antoine de Saint-Affrique highlighted the strategic opportunity to combine Huel's product range and digital capabilities with Danone's global reach and nutritional expertise, targeting the fast-growing market for nutritionally complete foods [1]. Huel, known for its vegan, powdered meal replacements and protein shakes fortified with nutrients, caters to health-conscious, time-poor consumers seeking environmentally sustainable meals [1]. The brand is backed by celebrities including Steven Bartlett and Idris Elba [1].
The deal comes amid a shift in consumer behavior, driven by a more health-conscious younger generation and the increased use of GLP-1 weight-loss drugs, prompting food companies to rethink their offerings [1]. Danone's portfolio, which includes yoghurts, water, and specialized nutrition products, is described as "extremely complementary" to these emerging trends [1]. Analysts at ING note that food makers are adapting through portion control, recipe tweaks, and premium products, with these changes expected to accelerate as GLP-1 adoption rises [1].
Currently, the impact of GLP-1 drugs in Europe is limited, with only about 2% of the adult population using them, but ING expects this number to grow [1]. The global market for GLP-1 drugs is projected by ING to reach $100 billion in 2027 [1]. Food makers are facing a gradual demand shift, allowing time to adjust products, marketing, and investments in markets with lower GLP-1 usage [1].
CONCLUSION
Danone's acquisition of Huel signals a strategic move to capitalize on evolving health and nutrition trends, particularly as weight-loss drugs reshape consumer demand. The deal positions Danone to expand its presence in the nutritionally complete food space, with analysts expecting continued adaptation across the industry. Market sentiment is positive, reflecting high impact and growth potential in health-focused nutrition.